🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Brain Tumor, Recurrent

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) NCT04427384n/a54 sites📍 Phoenix📍 Little Rock📍 Castro Valley GT Medical Technologies, Inc. · Tests: GammaTile Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors NCT07174661NA1 site📍 Scottsdale Mayo Clinic · Tests: Advance Care Planning, Educational Intervention, Electronic Health Record Review, Survey Administration Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial NCT06818331Phase 21 site📍 China The Third Affiliated hospital of Zhejiang Chinese Medical U… · Tests: SMES+PTX, Paclitaxel, Specific mode electroacupuncture stimulation A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients NCT06496971Phase 32 sites📍 Taipei📍 Taoyuan NaviFUS Corporation · Tests: Bevacizumab, Microbubble, Low-Intensity Focused Ultrasound Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor NCT05590689Phase 1, Phase 21 site📍 Münster Universität Münster · Tests: Gliolan, Radiodynamic therapy A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma NCT07464925Phase 13 sites📍 Tampa📍 Chicago📍 New York Tetragon Biosciences Ltd · Tests: GLIX1 Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction NCT07132190Phase 21 site📍 Boston Ayal A. Aizer, MD · Tests: Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations NCT05588141Phase 1, Phase 22 sites📍 Jacksonville📍 Bethesda National Cancer Institute (NCI) · Tests: Zotiraciclib Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma NCT07416188Phase 1, Phase 21 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… · Tests: LMP744, Conventional Surgery or Biopsy Chronic CED of TPT for Recurrent Malignant Glioma NCT06666712Phase 11 site📍 New York Jeffrey N. Bruce · Tests: Topotecan Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma NCT07506239NA1 site📍 San Francisco University of California, San Francisco · Tests: Laser Interstitial Thermal Therapy (LITT), Magnetic resonance imaging (MRI), Questionnaires Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases NCT07130786Phase 21 site📍 Boston Ayal A. Aizer, MD · Tests: Levetiracetam (Keppra) HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388Phase 13 sites📍 Birmingham📍 St Louis📍 Houston M.D. Anderson Cancer Center · Tests: G207 ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas NCT06838676Phase 220 sites📍 Aurora📍 Washington D.C.📍 Miami Nationwide Children's Hospital · Tests: ACT001 Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM NCT05902169Phase 356 sites📍 Phoenix📍 Los Angeles📍 Los Angeles CarThera · Tests: SonoCloud-9 (SC9), Carboplatin, Lomustine, Temozolomide Precision Medicine for Every Child With Cancer NCT05504772n/a11 sites📍 Adelaide📍 Brisbane📍 Hobart Australian & New Zealand Children's Haematology/Oncology Gr… · Tests: Whole Genome Sequencing, RNA seq, DNA Methylation, Targeted Panel Sequencing, High Throughput Sequencing (in vitro) Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma NCT06090903NA1 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biospecimen Collection, Magnetic Resonance Imaging, Medical Chart Review Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma NCT07100730Phase 39 sites📍 Gold Coast📍 Melbourne📍 Perth Telix Pharmaceuticals (Innovations) Pty Limited · Tests: TLX-101-Tx + Lomustine, TLX101-Tx Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy. NCT07632092n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: CT scan Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases NCT04899908Phase 22 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Stereotactic Radiation, AGuIX gadolinium-based nanoparticles, Placebo A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma NCT07428616Phase 220 sites📍 Birmingham📍 Phoenix📍 San Francisco Exelixis · Tests: Zanzalintinib Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) NCT06193759Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized… Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors NCT06914479Phase 11 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Ad-hCMV-Flt3L, Ad-hCMV-TK, Biospecimen Collection, Magnetic Resonance Imaging, Survey Administration Sitagliptin in Recurrent/Progressive Grade 4 Glioma NCT07541781Phase 11 site📍 Iowa City Kailin Yang, MD, PhD · Tests: Sitagliptin, Bevacizumab The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) NCT06283927n/a8 sites📍 San Francisco📍 Boston📍 Leuven Jasper Gerritsen · Tests: Re-resection, Temozolomide, Lomustine, Re-irradiation, Experimental therapy Surgical Resection of Latent Brain Tumors Prior to Recurrence NCT04810871NA1 site📍 Rochester Mayo Clinic · Tests: Brain Surgery Tessa Jowell BRAIN MATRIX - Platform Study NCT04274283n/a14 sites📍 Birmingham📍 Cambridge📍 Cardiff University of Birmingham · Tests: Matched Tumour and Blood Sample - Research Pathway, Matched Tumour and Blood Sample - NHS GMS pathway Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors NCT07424092Phase 22 sites📍 Utrecht📍 Pamplona Clinica Universidad de Navarra, Universidad de Navarra · Tests: DNX-2401 A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors. NCT06907043Phase 1, Phase 210 sites📍 Denver📍 Lake Mary📍 Boston Eikon Therapeutics · Tests: EIK1004-001 (IMP1707-001)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy